Plain-English translation of NCT07403201 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing whether a medication called DLBS 3233, when combined with clomiphene citrate (a common fertility medication), works better than clomiphene citrate alone for women with polycystic ovary syndrome (PCOS). PCOS is a common condition that affects hormone levels, menstrual cycles, and fertility. The study will look at whether the medication helps control blood sugar levels, support healthy egg development, and regulate menstrual cycles.
Women with PCOS often struggle with irregular periods, weight management, and fertility. Current treatments help some women, but doctors are looking for better combination approaches that might improve outcomes in multiple areas at once.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would be assigned to take either the new medication combined with a standard fertility drug, or the standard fertility drug alone. Throughout the study, your doctor will monitor your menstrual cycle, check your weight, and run blood tests to measure how well the treatment is working. The study involves regular check-ins at the hospital in Yogyakarta to track your progress.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Indonesia
Sponsor
Inlacinpenelitian
Enrollment target
~90 participants
Started
December 2021
Primary completion
January 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
prastika candra, s1
muhammadiyah university of yogyakarta
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.